DPP4 and COVID-19: Therefore, the administration of DPP-4 inhibitors to patients with diabetes and COVID-19 could have a meaningful role in the prevention of long-term complications of COVID-19 through their well-i dentified anti-fibrotic, anti-i nflammatory, cardioprotective and nephroprotective actions.11,12